Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancer-Reference-Cited by-同舟云学术

Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancer

Published:2021-07 Issue: Volume:69 Page:103457
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Yang Haitang,Sun Beibei,Xu Ke,He Yunfei,Zhang Tuo,Hall Sean R R,Tan Swee T.,Schmid Ralph A.,Peng Ren-Wang,Hu Guohong,Yao Feng^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference67 articles.

1. Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy;Verza;Cancers (Basel),2020

2. HDAC1 Substrate Profiling Using Proteomics-Based Substrate Trapping;Nalawansha;ACS Chem Biol,2018

3. Nonhistone protein acetylation as cancer therapy targets;Singh;Expert Rev Anticancer Ther,2010

4. Histone deacetylase inhibitors: emerging mechanisms of resistance;Robey;Mol Pharm,2011

5. Histone Deacetylase Inhibitors as Anticancer Drugs;Eckschlager;Int J Mol Sci,2017

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adaptor protein CEMIP reduces the chemosensitivity of small cell lung cancer via activation of an SRC-YAP oncogenic module;Acta Pharmacologica Sinica;2024-07-23

2. Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors;Epigenetics;2024-02-18

3. Photoactive Poly-L-Lysine gel with resveratrol-magnesium metal polyphenol network: A promising strategy for preventing tracheal anastomotic complications following surgery;Materials Today Bio;2024-02

4. Cancer epigenetics: from laboratory studies and clinical trials to precision medicine;Cell Death Discovery;2024-01-15

5. Predicting drug response from single-cell expression profiles of tumours;BMC Medicine;2023-12-01